Edition:
India

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

89.87USD
20 Apr 2018
Change (% chg)

$-1.82 (-1.98%)
Prev Close
$91.69
Open
$92.00
Day's High
$92.00
Day's Low
$89.12
Volume
292,575
Avg. Vol
441,875
52-wk High
$106.26
52-wk Low
$71.90

Chart for

About

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $17,634.10
Shares Outstanding(Mil.): 219.11
Dividend: 0.37
Yield (%): 1.81

Financials

  ABC.N Industry Sector
P/E (TTM): 20.99 20.98 40.93
EPS (TTM): 3.83 -- --
ROI: 10.14 11.72 62.12
ROE: 38.47 13.91 73.69

BRIEF-Amerisourcebergen Production At Pharmedium's Memphis Outsourcing Facility Remains Voluntarily Suspended

* PRODUCTION AT PHARMEDIUM'S MEMPHIS OUTSOURCING FACILITY REMAINS VOLUNTARILY SUSPENDED

02 Apr 2018

Kentucky sues drug distributor AmerisourceBergen over opioid epidemic

Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers.

08 Mar 2018

Kentucky sues drug distributor AmerisourceBergen over opioid epidemic

March 8 Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers.

08 Mar 2018

BRIEF-AmerisourceBergen Says Stockholders Rejected Proposal To Urge Board To Report On Governance Measures Implemented Related To Opioids

* AMERISOURCEBERGEN SAYS STOCKHOLDERS REJECTED PROPOSAL TO URGE BOARD TO REPORT ON GOVERNANCE MEASURES IMPLEMENTED RELATED TO OPIOIDS - SEC FILING Source text: (http://bit.ly/2HZhCXW) Further company coverage:

02 Mar 2018

BRIEF-Deal talks between Walgreens and AmerisourceBergen have ended without an agreement- CNBC‍​

* TALKS BETWEEN WALGREENS AND AMERISOURCEBERGEN ABOUT AN ACQUISITION OF THE WHOLESALE DRUG DISTRIBUTOR HAVE ENDED WITHOUT AN AGREEMENT - CNBC, CITING SOURCES‍​ Source text: http://cnb.cx/2HP99qj Further company coverage:

27 Feb 2018

Albertsons to buy Rite Aid as Amazon threat looms

(The Feb. 20 story was corrected to remove a reference to Albertsons dropping IPO plans in 2017 in paragraph 4)

21 Feb 2018

CORRECTED-UPDATE 4-Albertsons to buy Rite Aid as Amazon threat looms (Feb. 20)

Feb 20 U.S. grocer Albertsons Cos Inc said it would buy drug store chain Rite Aid Corp to create a company with $83 billion in annual revenue, giving it more clout to compete with bigger chains in an industry fearing the entry of Amazon.Com.

21 Feb 2018

Amerisource deal may not keep Walgreens competitive - analysts

Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative speciality pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.

13 Feb 2018

Amerisource deal may not keep Walgreens competitive: analysts

Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.

13 Feb 2018

PRESS DIGEST -Wall Street Journal - Feb 13

Feb 13 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

13 Feb 2018

Competitors

Earnings vs. Estimates